Massachusetts General Hospital (MG) — Boston, Massachusetts

Public research footprint of Massachusetts General Hospital (MG), compiled from the ClinicalTrials.gov public registry.

5,766

Registered studies

1,544

Active

770

Recruiting now

3,151

Completed

819

Stopped or withdrawn

Most-studied conditions

Recurrent Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma · Refractory Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma · mCRPC (Metastatic Castration-resistant Prostate Cancer) · EBV-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified

Recently updated registry entries

NCT06458907 — A Prospective, Randomized Multicenter Clinical Trial of the TricValve® Transcatheter… (Not Yet Recruiting)
NCT04924075 — Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL)… (Recruiting)
NCT07232069 — PRE-EMPT: Prospective RandomizEd Evaluation and Management of Premature aTherosclerosis (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Massachusetts General Hospital (MG)?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 04, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.